Picture Campus Berlin-Buch GmbH CBB Location of Future Innovation 650x100px

News > All

Total search results: 6897 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 67 68 69  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Indivumed GmbH. (4/22/15). "Press Release: Sysmex Inostics Announces Agreement with IndivuTest to offer Blood Based Mutation Testing". Mundelein, IL & Hamburg. 2015-04-22
Genedata AG. (4/21/15). "Press Release: Precision Medicine Software Genedata Profiler Launched at Bio-IT World". Boston, MA. 2015-04-21
Sygnis AG. (4/20/15). "Press Release: Sygnis Announces Global Launch of its Second Product Line – SunScript Reverse Transcriptase". Madrid & Heidelberg. 2015-04-20
Bruker Corporation. (4/20/15). "Press Release: Bruker Introduces Novel Solid-state NMR Probe with Ultra-high Spinning Frequency". Asilomar, CA. 2015-04-20
Bruker Corporation. (4/20/15). "Press Release: Bruker Announces Innovative, High-performance and Cost-effective NMR Solutions for the Pharmaceutical Industry". Asilomar, CA. 2015-04-20
Bruker Corporation. (4/20/15). "Press Release: Bruker Introduces Next-Generation GigaHertz NMR Technology at ENC 2015". Asilomar, CA. 2015-04-20
Shimadzu Corporation. (4/20/15). "Press Release: Notification of Changes of Top Management". 2015-04-20
Merck KGaA. (4/20/15). "Press Release: Global Strategic Partners Merck and Pfizer Initiate Phase III Study with Avelumab in Patients with Stage IIIb/IV Non-Small Cell Lung Cancer". Darmstadt & New York. 2015-04-20
Medigene AG. (4/20/15). "Press Release: Clinical Data of Medigene's Dendritic Cell (DC) Vaccines Presented at AACR Conference". Martinsried. 2015-04-20
BioOutsource Ltd.. (4/17/15). "Press Release: BioOutsource Ltd. Acquired by Sartorius Stedim Biotech. Takeover Expands SSB’s Service Portfolio". Glasgow. 2015-04-17
Sigma-Aldrich Corporation. (4/17/15). "Press Release: Sigma-Aldrich Expands Customer-Centric Model with Investments in Singapore that Localize World-Class Capabilities to Better Support Customers in Asia". Singapore. 2015-04-17
Cevec Pharmaceuticals GmbH. (4/17/15). "Press Release: Cevec Announces Appointment of Life Sciences Industry Expert Frank Ubags as Chief Executive Officer". Cologne. 2015-04-17
Merck Serono. (4/16/15). "Press Release: Alise Reicin Joins Merck Serono as Head of Global Clinical Development". Darmstadt. 2015-04-16
Medigene AG. (4/16/15). "Press Release: Medigene to Participate in Three Upcoming International Conferences". Martinsried. 2015-04-16
Formycon AG. (4/16/15). "Press Release: Formycon AG Successfully Completes Capital Increase from Approved Capital". Munich. 2015-04-16
Omeicos Therapeutics GmbH. (4/15/15). "Press Release: Omeicos Therapeutics Raises EUR 6.2 Million in Series A to Advance Lead Candidate in Atrial Fibrillation". Berlin. 2015-04-15
Sophia Genetics S.A.. (4/15/15). "Press Release: Sophia Genetics’ Technology to Be Used by University Hospitals in Cologne and Düsseldorf to Improve Diagnosis of Hereditary Breast and Ovarian Cancer Patients". Lausanne. 2015-04-15
NanoTemper Technologies GmbH. (4/15/15). "Press Release: NanoTemper Technologies Inaugurates New Subsidiaries in Cambridge, UK and Krakow, Poland". 2015-04-15
MC Services AG. (4/14/15). "Press Release: MC Services Further Expands Its Financial Communications Expertise with the Appointment of Fabian Lorenz as a Senior Consultant". Düsseldorf. 2015-04-14
4SC AG. (4/14/15). "Press Release: 4SC Signs Licensing and Development Agreement with Menarini for Resminostat in Asia-Pacific Excluding Japan". Planegg-Martinsried & Singapore. 2015-04-14
Boehringer Ingelheim. (4/13/15). "Press Release: Hydra Biosciences and Boehringer Ingelheim Enter Research Collaboration Focused on Renal Diseases and Disorders". Cambridge, MA & Ingelheim. 2015-04-13
Roche. (4/13/15). "Press Release: Roche Strengthens Oncology Translational Research Pipeline by Acquiring CAPP Medical". Pleasanton, CA. 2015-04-13
Accovion GmbH. (4/13/15). "Press Release: Accovion Signs Agreement to Be Acquired by Clinipace Worldwide". Frankfurt & Eschborn. 2015-04-13
MorphoSys AG. (4/13/15). "Press Release: MorphoSys to Receive Milestone Payment for Guselkumab Program in Psoriatic Arthritis". 2015-04-13
Merck KGaA. (4/13/15). "Press Release: Merck Appoints Udit Batra to Head Combined Life Science Business Following Pending Sigma-Aldrich Acquisition". Darmstadt. 2015-04-13
Santhera Pharmaceuticals. (4/9/15). "Press Release: Santhera Receives FDA Fast Track Designation for Raxone/Catena (idebenone) for theTreatment of Duchenne Muscular Dystrophy". Liestal. 2015-04-09
MorphoSys AG. (4/8/15). "Press Release: MorphoSys to Start Share Buy-Back Program". 2015-04-08
Roche. (4/8/15). "Press Release: EU Approves Roche's Avastin plus Chemotherapy for Women with Advanced Cervical Cancer". Basel. 2015-04-08
Biofrontera AG. (4/8/15). "Press Release: Biofrontera Stabilizes Shareholder Structure. Block Trade Completed Off-market – Biofrontera Enters Essential Growth Phase with Long-term Investors". Leverkusen. 2015-04-08
Prothena Corporation plc. (4/8/15). "Press Release: Prothena Announces Pricing of Public Offering of 3,300,000 Ordinary Shares". Dublin. 2015-04-08
Wilex AG. (4/8/15). "Press Release: Wilex AG Successfully Completes Rights Issue". Munich. 2015-04-08
Ipsen S.A.. (4/8/15). "Press Release: Ipsen and Hannover Medical School Start Joint Research in Recombinant Botulinum Neurotoxins for Targeted Secretion Inhibitors. Key Steps in Thirty Months Research Program Underway". Paris & Hannover. 2015-04-08
Blueberry Therapeutics Ltd.. (4/8/15). "Press Release: Blueberry Raises $1.75M in Investment". 2015-04-08
Nabriva Therapeutics AG. (4/7/15). "Press Release: Nabriva Therapeutics Announces Financing of up to $120M to Advance Clinical Development of New Class of Antibiotic". Vienna & Philadelphia, PA. 2015-04-07
Roche. (4/7/15). "Press Release: Roche Announces Preliminary Results of Tender Offer for Foundation Medicine, Inc.". Basel. 2015-04-07
CRISPR Therapeutics AG. (4/7/15). "Press Release: CRISPR Therapeutics to Establish R&D Operations in Cambridge, Massachusetts. Company Appoints Bill Lundberg, M.D., as Chief Scientific Officer". Basel & Cambridge, MA. 2015-04-07
Merck KGaA. (4/7/15). "Press Release: Global Strategic Partners Merck and Pfizer Finalize Agreement to Co-Promote Xalkori (crizotinib)". Darmstadt & New York. 2015-04-07
Sophia Genetics S.A.. (4/7/15). "Press Release: Sophia Genetics Expands in Germany and Austria with Significant New Clients in Karlsruhe, Mannheim and Vienna". Lausanne. 2015-04-07
Indivumed GmbH. (4/7/15). "Press Release: William R. Gruver Agrees to Lead Indivumed Business Advisory Team". Hamburg. 2015-04-07
Bruker Corporation. (4/3/15). "Press Release: Bruker Announces FDA Clearance for Second, Expanded Claim for the MALDI Biotyper CA System". Billerica, MA. 2015-04-03
GlaxoSmithKline plc. (4/2/15). "Press Release: GSK to Establish Global Vaccines R&D Centre in the US. New Hub Based in Rockville, MD Expands GSK’s Global Vaccines R&D Footprint". London & Philadelphia, PA. 2015-04-02
Qiagen N.V.. (4/2/15). "Press Release: Qiagen Announces Proposal for Re-election of All Current Supervisory Board Members at Next Annual General Meeting". Venlo. 2015-04-02
AMP Biosimilars AG. (4/2/15). "Corporate Presentation [April 2015]". Hamburg. 2015-04-02
PeptiDream Inc.. (4/2/15). "Press Release: PeptiDream Announces License of PeptiDream’s Peptide Discovery Platform System (PDPS) Technology to Novartis". Tokyo. 2015-04-02
AMP Biosimilars AG. (4/2/15). "Press Release: AMP Biosimilars AG – Second German “Pure Play” Biosimilars Listing. Successful Trading Launch on the Munich Stock Exchange". Hamburg. 2015-04-02
Caribou Biosciences, Inc.. (4/2/15). "Press Release: Caribou Biosciences Raises $11 Million in Series A Funding". 2015-04-02
Basilea Pharmaceutica Ltd.. (4/1/15). "Press Release: Basilea In-licenses Targeted Cancer Therapy". Basel. 2015-04-01
4SC AG. (4/1/15). "Press Release: Dr Susanne Danhauser-Riedl Joins 4SC as Chief Medical Officer to Strengthen Management and Clinical Development Team". Planegg-Martinsried. 2015-04-01
Merck KGaA. (4/1/15). "Press Release: Merck Serono and Medicines for Malaria Venture Sign Agreement to Develop Potential Antimalarial Therapy". Darmstadt. 2015-04-01
Bayer AG. (4/1/15). "Press Release: New Phase 3 Study in China Confirms Vision Improvement for Patients with Wet Age-Related Macular Degeneration when Receiving Aflibercept Solution for Intravitreal Injection [Not intended for U.S. and UK Media ]". Berli 2015-04-01
InflaRx GmbH. (4/15). "Press Release: InflaRx Receives Large Scale Government Grant from BMBF". 2015-04-01
Lead Discovery Center GmbH. (3/31/15). "Press Release: LDC and HZI Enter Partnership for the Discovery of New Drugs against Multi-resistant Bacteria". Dortmund. 2015-03-31
Bayer AG. (3/31/15). "Press Release: Personalized Cardiology. Bayer HealthCare Expands Collaboration with Broad Institute of MIT and Harvard to Develop Therapies for Cardiovascular Disease [Not intended for UK Media]". Leverkusen. 2015-03-31
Evolva Holding S.A.. (3/31/15). "Press Release: Evolva Publishes Financial Results for 2014". 2015-03-31
Direvo Industrial Biotechnology GmbH. (3/31/15). "Press Release: Direvo Announces the USPTO Issuance of a Patent Claiming the Use of Enzyme Mixes In Biorefineries". Cologne. 2015-03-31
Greenovation Biotech GmbH. (3/31/15). "Press Release: Greenovation and University of Freiburg Cooperate to Fight an Extremely Rare Disease". Freiburg. 2015-03-31
High-Tech Gründerfonds Management GmbH. (3/31/15). "Press Release: A Consortium Led by High-Tech Gründerfonds and Innovationsstarter Invests in Sonormed. E-health Solution Tinnitracks Can Alleviate Tinnitus". 2015-03-31
Merck KGaA. (3/30/15). "Press Release: Merck Serono and Intrexon Announce Agreement for the Development and Commercialization of CAR-T Therapy". Darmstadt. 2015-03-30
Novartis AG. (3/30/15). "Press Release: Novartis Accelerates Cancer Immunotherapy Efforts with Aduro Biotech Alliance and Launch of New Immuno-oncology Research Group". Basel. 2015-03-30
Pieris Pharmaceuticals, Inc.. (3/30/15). "Press Release: Pieris Pharmaceuticals and the University of Melbourne Receive Research Grant to Advance Immunological Diseases Program". Freising & Melbourne. 2015-03-30
MorphoSys AG. (3/30/15). "Press Release: MorphoSys Nominates Three New Candidates for Supervisory Board". 2015-03-30
Novartis AG. (3/30/15). "Press Release: Novartis Announces FDA Approval for Jadenu to Simplify Treatment Administration for Patients with Chronic Iron Overload". Basel. 2015-03-30
Bayer AG. (3/30/15). "Press Release: Bayer Issues EUR 1.3 Billion in Hybrid Capital". Leverkusen. 2015-03-30
BioMed X GmbH. (3/30/15). "Press Release: AbbVie and BioMed X Collaborate to Develop Novel Approaches for the Treatment of Alzheimer's Disease". Heidelberg. 2015-03-30
Biocartis N.V.. (3/26/15). "Press Release: Biocartis and Microbiome Sign Collaboration to Develop Rapid and Sensitive Sepsis Test". Mechelen & Amsterdam. 2015-03-26
MorphoSys AG. (3/26/15). "Press Release: MorphoSys and Celgene Mutually Agree to End MOR202 Collaboration. MorphoSys Regains Rights to MOR202 Antibody Against CD38 and Updates Its Financial Guidance for 2015". 2015-03-26
Evotec AG. (3/26/15). "Press Release: Asahi Kasei Pharma Selects Evotec as Its Partner for Ion Channel Drug Discovery". Hamburg. 2015-03-26
Bayer AG. (3/26/15). "Press Release: Bayer Receives Approval for Gadovist (gadobutrol) Injection in Japan [Not intended for U.S. and UK Media]". Leverkusen. 2015-03-26
Valneva S.E.. (3/26/15). "Press Release: Valneva Announces Approval of an EB66-based Prototype Influenza Vaccine in Japan". Lyon. 2015-03-26
Apceth GmbH & Co. KG. (3/26/15). "Press Release: Apceth Initiates Phase II Clinical Trial for Pioneering Engineered Cell Therapy to Treat Gastrointestinal Cancer". Munich. 2015-03-26
Wilex AG. (3/26/15). "Press Release: Wilex Announces Financial Figures for the 2014 Financial Year and Reports on Course of Business". Munich. 2015-03-26
Evolva Holding S.A.. (3/26/15). "Press Release: Evolva and Valent BioSciences to Co-develop Agricultural Bioactives". 2015-03-26
Analytik Jena AG. (3/26/15). "Press Release: Analytik Jena AG Leaves the Stock Exchange". Jena. 2015-03-26
4SC AG. (3/25/15). "Press Release: 4SC Publishes Results for Financial Year 2014". Planegg-Martinsried. 2015-03-25
Pieris Pharmaceuticals, Inc.. (3/25/15). "Press Release: Pieris Pharmaceuticals Reports Full-Year 2014 Financial Results and Provides Corporate Update". Freising. 2015-03-25
Biofrontera AG. (3/25/15). "Press Release: Biofrontera Starts Sales and Marketing of Ameluz in Spain. Key Account Manager Transfers from Allergan to Biofrontera". Leverkusen. 2015-03-25
Mologen AG. (3/25/15). "Press Release: Start of Pivotal Study for Cancer Immunotherapy MGN1703 Influences 2014 Annual Result". 2015-03-25
Epigenomics AG. (3/25/15). "Press Release: Epigenomics Announces Completion of Enrollment in Epi proColon ADMIT Trial". Berlin & Germantown, MD. 2015-03-25
Epigenomics AG. (3/25/15). "Press Release: Epigenomics AG Reports Results for the Financial Year Ended December 31, 2014 and Provides Outlook for 2015". Berlin & Germantown, MD. 2015-03-25
Affimed N.V.. (3/25/15). "Press Release: Affimed Announces Financial Results for Fourth Quarter and Year End 2014". Heidelberg. 2015-03-25
BIA Separations GmbH. (3/25/15). "Press Release: BIA Separations Appoints Hichrom as Distributor". 2015-03-25
Medigene AG. (3/25/15). "Press Release: Medigene Publishes Final Financials 2014. Significant Improvement in Revenue, EBITDA and Net Result". Martinsried. 2015-03-25
Cytos Biotechnology AG. (3/25/15). "Press Release: Novartis Buys Out CAD 106 License Agreement for CHF 4 Million". Schlieren. 2015-03-25
High-Tech Gründerfonds Management GmbH. (3/24/15). "Press Release: Rigontec GmbH Raises €4.8m in a Second Closing of Its Series A Financing. Brings Series A Total to €14.25m to Advance RNA-based Immunotherapeutics for Cancer and Viral Diseases". 2015-03-24
Evotec AG. (3/24/15). "Press Release: Evotec FY 2014 – Strong Performance in EVT Execute and Acceleration of EVT Innovate". Hamburg. 2015-03-24
Medigene AG. (3/24/15). "Press Release: Medigene Starts Phase I/II Study with DC Vaccine to Treat Acute Myeloid Leukaemia (AML)". Martinsried. 2015-03-24
Affimed N.V.. (3/24/15). "Press Release: Affimed Completes TandAb Development Candidate Activities Meeting Amphivena’s and Janssen’s Criteria and Achieves Milestone Ahead of Schedule". Heidelberg. 2015-03-24
JPIF Management B.V.. (3/23/15). "Press Release: Poland’s First Institutional Venture Capital Fund Dedicated to Life Science Announces First Closing At $ 42 Million". Warsaw. 2015-03-23
HalioDx S.A.S.. (3/23/15). "Press Release: Creation of HalioDx. A Management Buy-out by the Qiagen Marseille Executive Team". Marseille. 2015-03-23
BIOPRO Baden-Württemberg GmbH [KS]. (3/23/15). "Press Release: Cytena GmbH Facilitates the Separation of Single Cells". 2015-03-23
Life Science Nord. (3/20/15). "Press Release: The Netherlands in North Germany. Life Science Startups Present Innovative Technologies to Members of the Delegation". Hamburg & Schleswig-Holstein. 2015-03-20
Novartis AG. (3/20/15). "Press Release: New Novartis Data Shows Cosentyx Is Significantly Superior to Stelara and Clears Skin (PASI 90) in Nearly 80% of Psoriasis Patients". Basel. 2015-03-20
Evotec AG. (3/20/15). "Press Release: Evotec and Sanofi Sign Definitive Agreement for Major Multi-component Strategic Alliance. Total Deal Value of EUR 250 m, including more than EUR 40 m Upfront Cash Payment". Hamburg. 2015-03-20
Boehringer Ingelheim. (3/20/15). "Press Release: Boehringer Ingelheim’s Investigational Biologic Cleared Skin Better than Ustekinumab in Head-to-head Phase II Psoriasis Study [For non-UK / non-Canadian media only]". San Francisco, CA & Ingelheim. 2015-03-20
Sygnis AG. (03/18/15). "Press Release: Sygnis Signs Non-exclusive Distribution Agreement with Sopachem for TruePrime Product Family in Belgium". Madrid. 2015-03-19
GATC Biotech AG. (3/19/15). "Press Release: GATC Biotech Becomes First European Services Provider Offering Full Access to Qiagen’s Ingenuity Variant Analysis". Constance. 2015-03-19
Roche. (3/19/15). "Press Release: Roche Announces Global Distribution Agreement for Its Biochemical Reagents Product Portfolio with Sigma-Aldrich". Pleasanton, CA. 2015-03-19
Tecan Group Ltd.. (3/18/15). "Press Release: Tecan with Strong Order Entry and Good Sales Development in the Second Half of 2014. Financial Results – Full-year and Second Half of 2014". Männedorf. 2015-03-18
Tecan Group Ltd.. (3/18/15). "Press Release: Lars Holmqvist to Be Proposed to the Upcoming Annual General Meeting as a New Member of the Board of Tecan". Männedorf. 2015-03-18
Scienion AG. (3/18/15). "Press Release: Scienion US, Inc. Receives ISO 13485 Certification". Monmouth Junction, NJ. 2015-03-18
next pagenext page 1 2 3 ... 67 68 69  next pagenext page


Picture [iito] Männer Ballett 650x100px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture Campus Berlin-Buch GmbH BBC BerlinBioCube Start-up Center 650x300px

» top